Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

Recruiting N/A Interventional Study
Post COVID-19 Condition Post-COVID-19 Syndrome Post-COVID Syndrome COVID-19 Fatigue Fatigue Syndrome, Chronic
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Sunnybrook Health Sciences Centre · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Over 500 million people have been infected with COVID-19, and to date, more than 6 million people have died. Many individuals who have recovered from COVID-19 continue to experience symptoms even after they have been "cured" of the disease. This condition is known as post COVID-19 condition, which can have serious health consequences. A common symptom among these individuals is chronic fatigue, ch…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years old 2. Officially diagnosed with post COVID-19 condition by a healthcare practitioner 3. At least three months since SARS-CoV-2 infection 4. Symptoms that persist more than 12 weeks: * Chronic fatigue (must include) along with one of the following symptoms:…
Contacts

Fahad Alam, MD

416-480-4864

fahad.alam@sunnybrook.ca

CONTACT

Lilia Kaustov, PhD

416 480-6100

lilia.kaustov@sunnybrook.ca

CONTACT